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Abstract
Background: The aim of this study was to characterise the microbiome of new and recurrent diabetic foot ulcers
using 16S amplicon sequencing (16S AS), allowing the identification of a wider range of bacterial species that may
be important in the development of chronicity in these debilitating wounds. Twenty patients not receiving
antibiotics for the past three months were selected, with swabs taken from each individual for culture and
16S AS. DNA was isolated using a combination of bead beating and kit extraction. Samples were sequenced
on the Illumina Hiseq 2500 platform.
Results: Conventional laboratory culture showed positive growth from only 55 % of the patients, whereas
16S AS was positive for 75 % of the patients (41 unique genera, representing 82 different operational taxonomic
units (OTU’s). S. aureus was isolated in 72 % of culture-positive samples, whereas the most commonly detected
bacteria in all ulcers were Peptoniphilus spp., Anaerococcus spp. and Corynebacterium spp., with the addition of
Staphylococcus spp. in new ulcers. The majority of OTU’s residing in both new and recurrent ulcers (over 67 %)
were identified as facultative or strict anaerobic Gram-positive organisms. Principal component analysis (PCA)
showed no difference in clustering between the two groups (new and recurrent ulcers).
Conclusions: The abundance of anaerobic bacteria has important implications for treatment as it suggests that
the microbiome of each ulcer “starts afresh” and that, although diverse, are not distinctly different from one
another with respect to new or recurrent ulcers. Therefore, when considering antibiotic therapy the duration of
current ulceration may be a more important consideration than a history of healed ulcer.
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Background
A serious complication of diabetes is the development of
foot ulcers. Patients with diabetes are believed to have a
12–25 % lifetime risk of developing a foot ulcer [1]. The
aetiology of diabetic foot ulceration is complex. Foot ul-
cers often develop due to a combination of intrinsic fac-
tors, such as peripheral neuropathy, poor extremity
perfusion, foot deformity, changes to the plantar foot
soft tissues plus extrinsic mechanical factors, such as
high plantar pressures [2]. Diabetic foot ulcers have a
significant negative impact on health and quality of life
and are the most common cause of hospitalisation in pa-
tients with diabetes [3].
Diabetic foot ulcers often heal very slowly, due to
diabetes-associated micro-vascular disease and impaired
host immune response, and these open wounds provide
a niche for infection [4, 5]. Bacteria can exist within the
wound as multi-layered microbial communities, known
as biofilms, surrounded by a self-produced protective
extracellular ‘slime’ [6]. The presence of a biofilm makes
infections very difficult to resolve, as the structure
shields the encased cells from antimicrobial agents and
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the host immune system, allowing bacteria to persist
and impair healing [7]. Many foot ulcers fail to heal and
cause serious complications, such as osteomyelitis. Infec-
tion is the most common cause of lower limb amputa-
tion in diabetic foot ulcers [3]. In the UK, more than
one hundred amputations are carried out each week in
individuals with diabetes [1]. In addition to the signifi-
cant trauma, the cost to the NHS of treating infected
diabetic foot ulcers and resulting amputations is esti-
mated to be in the region of £900 million per year [8].
Standard treatment of diabetic foot ulcers involves de-
bridement of the necrotic tissue, management of infection
and off-loading of the ulcer [9]. Infection is routinely con-
firmed by laboratory culture of bacteria in a swab taken
from the wound. Culture-dependent methods show bias
towards microorganisms that are able to grow well on la-
boratory culture media. More fastidious organisms may
not be identified, resulting in a delay in the appropriate
treatment [10, 11]. Molecular methods are advancing and
becoming more accessible and affordable (including 16S
amplicon sequencing [16S AS]), and it is now possible to
use bacterial DNA from the wound site to identify the
pathogens present [12]. A greater understanding of both
the bacteria present in diabetic foot ulcers and how these
bacteria interact with one another, and the host, will be
crucial for the development of reliable models of infection
and effective treatments.
It was our hypothesis that the specific microbiome as-
sociated with new and recurrent diabetic foot ulcers dif-
fered, and that this impacted the ability to effectively
manage these wounds. Therefore, the aim of this study
was to use 16S AS technologies to characterise the
microbiome of new and recurrent ulcers and to under-
take comparative analyses to gain understanding of
whether the presence of certain microorganisms were
associated with the inability of an ulcer to heal.
Results
The detection of bacteria in diabetic foot ulcers by
conventional laboratory culture and molecular methods
By conventional laboratory culture, 11 samples (55 %)
were positive for microbial growth by standard aerobic
and anaerobic culture methods (4 recurrent ulcer sam-
ples and 7 new ulcer samples) (Table 1). The remaining
9 swab samples (45 %) produced no significant growth
(6 recurrent and 3 new ulcer samples). In the samples
that were positive for bacterial growth, 6 contained more
than one species. S. aureus was isolated in 8 of culture-
positive samples, anaerobes were isolated from 4 sam-
ples, beta-haemolytic streptococci from 2 samples, and
Candida spp. was identified alone in only 1 sample. One
control swab sample collected from the healthy skin
(sample 19) showed a moderate growth of S. aureus.
These results are summarised in Table 1. Moreover, S.
aureus was confirmed in 50 % of the samples tested by
PCR. Spearman’s rank correlation showed that this cor-
related to culture results (p < 0.05, CI 0.5761–0.9642).
Microbiome analysis diabetic foot ulcers by 16S amplicon
sequencing
DNAwas successfully amplified and sequenced from 16 of the
samples (75 %), including 9 from new ulcers and 7 from recur-
rent ulcers. These 16 samples produced an average of 1,767,142
sequence reads, which were filtered for quality and assigned an
OTUusing aminimum sequence similarity of 97 %. The abun-
dance of each species in wound samples of greater than 0.5 %
was reported. Raw data sets are available from the following
website: http://www.ncbi.nlm.nih.gov/bioproject/304940.
In the 16 ulcer samples there were 41 unique genera,
representing 82 different OTU’s, which ranged from 21
different species (sample 4) to only 2 species (sample 9).
The species identified in new and non-healing ulcers are
displayed in Table 2, along with their frequency of detec-
tion. In new ulcers there were 94 different OTU’s
identified; most frequently detected genera were Pep-
toniphilus (6 samples), Staphylococcus (5 samples),
Anaerococcus (5 samples) and Corynebacterium (4 samples).
In recurrent ulcers 73 unique OTU’s were identified;
Table 1 Clinical laboratory culture of diabetic foot wound
samples
Sample number New or recurrent ulcer Bacteria isolated
1 Recurrent NSGa
2 Recurrent NSG
3 Recurrent Candida spp.
4 New Mixed growth + anaerobe
5 New Mixed growth + anaerobe
6 Recurrent S. aureus + anaerobe
7 New S. aureus + anaerobe
8 New NSG
9 New S. aureus + beta-haemolytic
Streptococcus (Group G)
10 Recurrent NSG
11 New NSG
12 New S. aureus
13 New S. aureus + beta-haemolytic
Streptococcus (Group G)
14 Recurrent S. aureus
15 Recurrent NSG
16 Recurrent NSG
17 New S. aureus
18 New NSG
19 Recurrent S. aureus
20 Recurrent NSG
aNSG - No significant growth
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Table 2 List of species identified in the new and recurrent ulcers by 16S AS
Species identified No. of samples Gram type Oxygen tolerance
New Recurrent
Actinobaculum massiliense 1 0 Gram Positive Facultative anaerobe
Actinobaculum schaalii 2 2 Gram Positive Facultative anaerobe
Actinomyces europaeus 0 1 Gram Positive Facultative anaerobe
Actinomyces hominis 0 1 Gram Positive Facultative anaerobe
Actinomyces neuii 0 1 Gram Positive Facultative anaerobe
Actinomyces radingae 0 1 Gram Positive Facultative anaerobe
Alcaligenes faecalis 0 1 Gram Negative Aerobe
Anaerococcus murdoch 3 2 Gram Positive Anaerobe
Anaerococcus tetradius 1 0 Gram Positive Anaerobe
Anaerococcus vaginalis 5 4 Gram Positive Anaerobe
Bacteriodes fragilis 2 0 Gram Negative Anaerobe
Bilophila wadsworthia 1 0 Gram Negative Anaerobe
Bulleidia extructa 1 0 Gram Positive Anaerobe
Campylobacter ureolyticus 2 1 Gram Negative Anaerobe
Clostridium saccharogumia 2 0 Gram Positive Anaerobe
Corynebacterium accolens 0 1 Gram Positive Facultative anaerobe
Corynebacterium amycolatum 4 0 Gram Positive Facultative anaerobe
Corynebacterium aurimucosum 2 1 Gram Positive Facultative anaerobe
Corynebacterium freiburgense 0 1 Gram Positive Facultative anaerobe
Corynebacterium hansenii 1 0 Gram Positive Facultative anaerobe
Corynebacterium mycetoide 0 1 Gram Positive Facultative anaerobe
Corynebacterium simulans 1 3 Gram Positive Facultative anaerobe
Corynebacterium tuberculostearicum 1 0 Gram Positive Facultative anaerobe
Corynebacterium xerosis 1 0 Gram Positive Facultative anaerobe
Dermabacter hominis 2 2 Gram Positive Facultative anaerobe
Dialister propionicifaciens 1 0 Gram Negative Anaerobe
Dialister micraerophilus 1 0 Gram Negative Anaerobe
Dialister pneumosintes 1 0 Gram Negative Anaerobe
Eggerthella lenta 1 0 Gram Positive Anaerobe
Enterobacter hormaechei 0 2 Gram Negative Facultative anaerobe
Enterococcus canintestini 0 2 Gram Negative Facultative anaerobe
Escherichia fergusonii 0 1 Gram Negative Facultative anaerobe
Escherichia vulneris 0 1 Gram Negative Facultative anaerobe
Finegoldia magna 5 5 Gram Positive Anaerobe
Fusobacterium canifelinum 1 0 Gram Negative Anaerobe
Fusobacterium nucleatum 1 0 Gram Negative Anaerobe
Fusobacterium periodontium 1 0 Gram Negative Anaerobe
Gemella morbillorum 0 1 Gram Positive Anaerobe
Granulicatella adiacens 0 1 Gram Positive Facultative anaerobe
Haemophilus parainfluenzae 1 1 Gram Negative Facultative anaerobe
Helcococcus kunzii 1 2 Gram Positive Anaerobe
Kocuria atrinae 1 Gram Positive Anaerobe
Leclercia adecarboxylata 0 2 Gram Negative Facultative anaerobe
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the most frequently detected genera were Corynebac-
terium (5 samples), Peptoniphilus (4 samples) and
Anaerococcus (4 samples). The relative abundance (%)
of each genus is displayed in Fig. 1 for new ulcers and
Fig. 2 for recurrent ulcers. Dominance and Diversity
indices indicated a increase in diversity on the recur-
rent ulcers (Fig. 3), while the new ulcers had higher
levels of dominance. However, these differences were
not statistically significant (unpaired t-test, Shannon
value p = 0.3287, Dominance value p = 0.1649).
Table 2 List of species identified in the new and recurrent ulcers by 16S AS (Continued)
Mobiluncus curtisii 0 1 Gram Positive Anaerobe
Morganella morganii 0 1 Gram Negative Facultative anaerobe
Moryella indoligenes 0 1 Gram Positive Anaerobe
Negativicoccus succinicivorans 1 1 Gram Negative Anaerobe
Parvimonas micra 1 0 Gram Positive Anaerobe
Peptoniphilus gorbachii 4 4 Gram Positive Anaerobe
Peptoniphilus ivorii 2 3 Gram Positive Anaerobe
Peptoniphilus lacrimalis 2 1 Gram Positive Anaerobe
Peptoniphilus olsenii 2 0 Gram Positive Anaerobe
Peptostreptococcus anaerobius 2 0 Gram Positive Anaerobe
Peptostreptococcus stomatis 1 0 Gram Positive Anaerobe
Porphyromonas asaccharolytica 3 2 Gram Negative Anaerobe
Porphyromonas bennonis 2 1 Gram Negative Anaerobe
Porphyromonas somerae 2 2 Gram Negative Anaerobe
Porphyromonas uenonis 1 1 Gram Negative Anaerobe
Prevotella bergensis 1 1 Gram Negative Anaerobe
Prevotella buccalis 2 0 Gram Negative Anaerobe
Prevotella corporis 1 0 Gram Negative Anaerobe
Prevotella intermedia 1 0 Gram Negative Anaerobe
Prevotella timonensis 1 1 Gram Negative Anaerobe
Proteus myxofaciens 0 1 Gram Negative Anaerobe
Pseudomonas indica 0 1 Gram Negative Aerobe
Pseudomonas otitidis 0 1 Gram Negative Aerobe
Psychrobacter lutiphocae 1 0 Gram Negative Aerobe
Serratia grimesii 0 1 Gram Negative Facultative anaerobe
Staphylococcus carnosus 1 0 Gram Positive Facultative anaerobe
Staphylococcus chromogenes 2 0 Gram Positive Facultative anaerobe
Staphylococcus devriesei 1 0 Gram Positive Facultative anaerobe
Staphylococcus hominis 5 2 Gram Positive Facultative anaerobe
Staphylococcus pettenkoferi 1 0 Gram Positive Facultative anaerobe
Staphylococcus saprophyticus 0 1 Gram Positive Facultative anaerobe
Stenotrophomonas pavanii 0 1 Gram Negative Aerobe
Streptococcus agalactiae 2 0 Gram Positive Facultative anaerobe
Streptococcus anginosus 0 1 Gram Positive Facultative anaerobe
Streptococcus canis 1 0 Gram Positive Facultative anaerobe
Streptococcus dysgalactiae 1 0 Gram Positive Facultative anaerobe
Streptococcus infantarius 1 2 Gram Positive Facultative anaerobe
Varibaculum cambriense 0 1 Gram Positive Anaerobe
Veillonella dispar 1 0 Gram Negative Anaerobe
Veillonella rogosae 1 0 Gram Negative Anaerobe
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Fig. 1 Abundance (%) of bacterial genus within new diabetic foot ulcers
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Fig. 2 Abundance (%) of bacterial genus within recurrent diabetic foot ulcers
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The majority of OTU’s residing in both new and re-
current ulcers (over 67 %) were identified as Gram-
positive organisms. These were mostly Gram-positive
cocci, such as Staphylococcus, Streptococcus, Anaero-
coccus, Peptoniphilus and Finegoldia. However, the
Gram-positive rods, Corynebacterium, Clostridium and
Actinomyces were also frequently detected. In both
types of ulcers the most frequently identified Gram-
negative organisms were Porphyromonas spp. In all
sixteen ulcers sampled the majority of species identi-
fied by 16S AS were classed as facultative or strict
anaerobes. In newly formed ulcers, only one of the 94
OTU’s identified (1.06 %) was an aerobe and in recur-
ring ulcers, 4 of the 73 OTU’s identified (5.48 %)
were aerobes. The results at OTU’s level are outlined
in Table 2. Comparison of the bacterial classes and
genera within each group showed a significant differ-
ence (p < 0.05) between the amount of Gammaproteo-
bacteria in the two groups. There were no other
significant differences. In principal component (PC)
analysis (Fig. 4), PC1 was significantly different (p =
0.0229) between the two groups once the outlier sam-
ple (sample 13) was removed. However, we were un-
able to determine which bacteria are contributing to
this difference due to a lack of clear clusters in
graphical format.
Ulcer and clinical characteristics correlations
Both HbA1c and the duration of the patient’s diabetes
had correlated with dominance (p = 0.0174) and diver-
sity (p = 0.0168) values. A lower HbA1c value and
shorter duration of diabetes correlated with the
higher diversity (lower dominance statistic and higher
Shannon value) within the ulcer. No other ulcer char-
acteristics, including predominant genera identified by
16S AS, number of OTUs, oxygen tolerance and bac-
terial morphology, had any correlation with the pa-
tient’s characteristics.
Discussion
Diabetic foot ulcers are a common complication of
poorly controlled diabetes and are a significant cause of
morbidity and hospitalisation in sufferers of this disease
[3]. These debilitating wounds heal slowly and in severe
cases, lower extremity amputation may be the only clin-
ical option [1]. For many years the role of bacteria in
chronic wound healing was often overlooked, as ap-
proximately half of diabetic foot ulcers exhibit no clinical
evidence of infection [13]. However, many individuals
with diabetes have an impaired inflammatory response
and may not show the classical signs of infection in a
wound with a high microbial burden [14]. The concept
that non-healing in chronic wounds is associated with
Fig. 3 Dominance and diversity (Shannon Value) indices for both sets of ulcers
Fig. 4 Principal Component Plots. New ulcers (black circles) and recurrent ulcers (red circles) were plotted with a and (b) without sample 13
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bacterial load was introduced [5, 15], and bacterial col-
onisation and proliferation within diabetic foot ulcers is
now believed to significantly retard wound healing.
Therefore, a greater understanding of the microbiome of
these chronic wounds is urgently required to help guide
the successful treatment [16]. Here we report for the
first time the complex microbiome of new and recurrent
ulcers, demonstrating how diverse polymicrobial biofilm
populations are common in diabetic patients. This is of
significance as there is growing evidence that polymicro-
bial interactions may synergise the pathogenic potential
of one or other microorganism [17]. This has implica-
tions for patient management, as eradication of microor-
ganisms could be important in controlling these chronic
wounds [7, 18, 19].
In the clinic, infection is generally suspected based
on the presence of at least two classic signs of inflam-
mation (erythema, warmth, tenderness, pain or indur-
ation) or purulent secretions [20]. The standard
method of diagnosis is by traditional laboratory cul-
ture of a sample taken directly from the wound. Our
study relied on swab sampling rather than wound bi-
opsy because there was a desire to limit the use of in-
vasive procedures. The presence of bacteria was
detected in ten of the twenty swab samples cultured.
All other samples produced no significant growth.
Standard laboratory reporting only provided basic in-
formation and did not readily identify the precise spe-
cies present in the majority of samples, though S.
aureus was the most commonly isolated pathogen
(40 % of samples). It has been well documented in
studies of diabetic foot ulcers that S. aureus is the
most commonly detected pathogen by laboratory cul-
ture [21, 22]. The frequent identification may be due
to the ability of staphylococci to grow under normal
laboratory conditions when these methods often fail to
identify slow-growing, fastidious or anaerobic organ-
isms [23]. This does not mean that these organisms
are an insignificant coloniser of chronic wounds. In a
retrospective study, it was found that 79 % of wounds
sampled were infected with S. aureus [21]. More
alarmingly, 30 % of these isolates were methicillin re-
sistant S. aureus (MRSA). In this study 7 of the 8
Staphylococcus isolates detected in our study were re-
sistant to penicillin in culture, and 3 of these isolates
were positive for mecA by PCR. Therefore, culture-
based methods still play an important role in patient
management, but do not necessarily give a true repre-
sentation of the pathogenic burden.
Conventional culture techniques have a tendency to
produced false negative results, with over 37 % of sam-
ples showing no signs of infection by culture alone. It is
now widely accepted that past reliance on standard cul-
ture techniques has led to an underestimation of the
microbiome of chronic wounds, only detecting approxi-
mately 1 % of the inhabiting bacteria, which is biased by
selective culture [16, 23]. Recent studies using molecular
methods have confirmed that chronic wounds, including
diabetic foot ulcers, have a polymicrobial nature instead
of being colonised by a single species [24]. In this study,
the number of OTU’s in a new ulcer samples ranged
from 2 to 21, and in recurrent ulcers species ranged
from 6 to 17. There is growing evidence that, as with
other persistent infections, the bacteria that reside
within chronic wounds grow within biofilm communities
[18, 19, 25]. This was supported by studies utilising mi-
croscopy that have shown that specimens from 60 % of
chronic wounds contained polymicrobial biofilm struc-
tures [6]. The presence of bacterial cells encased within
a biofilm may contribute to the chronicity of infection,
as biofilm-associated cells are notoriously recalcitrant.
Poor penetration of the biofilm structure and extracellu-
lar matrix, nutrient limitation leading to slow growth
and phenotypic variants, protect the cells from the ef-
fects of antimicrobials and the host immune response
[7, 18]. The eradication of polymicrobial biofilms
within diabetic foot ulcers could key to resolving these
chronic wounds.
The analysis of the microbiome of this patient group
showed that the most frequently identified genera were
the Gram-positive facultative anaerobes, Staphylococcus
and Corynebacterium. These organisms are part of the
normal microbiota of healthy skin particularly in moist
areas, such as the foot [26, 27]. Dowd et al. hypothesised
the concept that individual bacterial species may not be
able to maintain a pathogenic biofilm alone, but in a
symbiotic polymicrobial community in a DFU, patho-
genic biofilm may form [24]. Therefore, although these
bacteria are normally commensals, they may be contrib-
uting to a pathogenic community. In our study, S. aur-
eus was not detected by 16S AS, instead all species
identified were coagulase-negative staphylococci (CoNS).
We confirmed the presence of S. aureus DNA in these
samples using PCR, so while 16S AS is undoubtedly ro-
bust at the genus level results expressed at species level
should be interpreted with some caution. This under-
lines the current problem with using data from 16S AS
at the species level [28]. In the past, CoNS and Coryne-
bacterium spp. have been dismissed as contaminants of
normal skin flora in diabetic foot ulcers, but several
studies have highlighted their importance as potential
pathogens. In the case of CoNS, there is a link between
the presence of these species in diabetic foot ulcers and
the incidence of osteomyelitis [29, 30]. Armstrong et al.
(1995) studied a predominantly diabetic patient group
with osteomyelitis and found that 40 % of bone cultures
were positive for CoNS, 63 % of which were resistant to
the antibiotic methicillin [29]. A high incidence of
Smith et al. BMC Microbiology  (2016) 16:54 Page 7 of 12
Corynebacterium spp. has also been reported in studies
using both culture and molecular tools to analyse the
bio-burden of diabetic foot ulcers [24, 31, 32], and com-
bined with our findings highlights the importance of
CoNS and Corynebacterium spp. in relation to chronic
wounds, particularly in individuals with diabetes who
may have an impaired immune response [22, 29–32].
In the biological niche of the diabetic ulcer the com-
bination of necrotic tissue and low oxygen tension pro-
motes the proliferation of facultative or obligate
anaerobes [14, 33]. The majority of OTU’s identified in
our study conform to this logic, with obligate anaerobes
making up 65.9 % of the OTU’s in new ulcers and
56.1 % in recurrent ulcers. Only 1 OTU detected in new
ulcers and 4 OTU’s in recurrent ulcers were aerobic or-
ganisms. By culture our study was only able to identify
anaerobes in 25 % samples tested but by 16S AS anaer-
obes were found in 87.5 % of samples screened. The
most frequently identified anaerobes in new ulcers were
in the genera Peptoniphilus (6/9 new ulcers), Anaerococ-
cus (5/9 new ulcers), Finegoldia (5/9 new ulcers), Por-
phyromonas (4/9 new ulcers), and Prevotella (3/9 new
ulcers). In recurring ulcers the most frequently identified
anaerobes were also Finegoldia (5/7 recurring ulcers),
Peptoniphilus (4/7 recurring ulcers), Anaerococcus (4/7
recurring ulcers), Porphyromonas (2/7 recurring ulcers),
with the addition of Actinomyces (4/7 recurring ulcers),
which was not detected in new ulcers. The obligate an-
aerobes occurred as part of a polymicrobial microbiome
in all cases, and in previous studies this has earned them
the name of ‘co-pathogens’, playing down their import-
ance [20]. The fact that anaerobes were detected in over
87 % of the ulcers screened in our study suggests that
they may have a much more important role. Our data
agrees with three previous molecular studies of chronic
wounds which discovered a high incidence of anaerobic
organisms including Anaerococcus, Finegoldia and Pep-
toniphilus [11, 24, 32, 34]. Although wounds are gener-
ally exposed to air, anaerobes may be able to survive if
they co-aggregate with facultative anaerobes or aerobe
within a polymicrobial biofilm structure, which would
protect them from the harmful effects of oxygen and
allow them to thrive [35]. The virulence of anaerobic or-
ganisms has also recently been highlighted in a study of
Finegoldia magna, found in 62.5 % of ulcers in our
study, which revealed that this pathogen produces an
extracellular serine protease (SufA) to degrade collagen
in the skin basement membrane [36]. Using such mech-
anisms, anaerobes may be responsible for much of the
pathogenesis associated with chronic diabetic foot
ulcers.
The levels of Gammaproteobacteria in the two groups
were also found to be significantly different, with the re-
current group having a higher level. This class of
bacteria includes Enterobacteriaceae and Pseudomona-
dales. Our findings correlate with a culture-based study
that reported a high incidence of members of the
Pseudomonas, Enterococcus and Enterobacteriaceae
groups in moderate to severe diabetic foot ulcers [22]. It
is well documented that Pseudomonas aeruginosa is fre-
quently isolated from infected diabetic foot ulcers where
it is thought to play a role in severe tissue damage [37].
Clinical isolates of this organism collected from chronic
wounds may also be multi-drug resistant which makes
them very difficult to eradicate with antibiotic therapy
[37]. In a longitudinal study of wound microbiota in an
animal diabetic ulcer model it was reported that as time
progressed there was a significant shift in bacterial type
from Furmicutes to genera including Enterobacter,
which produced a corresponding decline in wound heal-
ing [26, 38]. This shift towards the presence of enteric-
types of bacteria in the recurrent wound may be a result
of self-colonisation from another body site. No other sig-
nificant differences were found between the two groups,
including in diversity (Fig. 3). There was no difference
between the two groups in bacteria with different oxygen
tolerance or number of OTU. There was a significant
difference in the number of Gram-positives in each
group, the recurrent group having less Gram-positive
bacteria. When further broken down into morphological
types this difference was no longer significant. This dif-
ference in Gram positive/negative balance could be
accounted for by the difference in levels of Gammapro-
teobacteria. Additionally PCA analysis (Fig. 4) indicated
no formation of distinct groups. Further longitudinal in-
vestigations monitoring the ulcer microbiome over time
will help determine if the presence of certain species are
associated with the chronicity of these wounds and the
inhibition of healing.
As lower HbA1c levels and a shorter duration of dia-
betes correlated with higher diversity within the ulcer
this suggests that poorly glycaemic control and per-
sistent diabetes causes a dominant bacterial species to
rise within the ulcer. In contrast, Gardner et al. found
that there was no link between high HbA1c levels and
diversity, but instead poor glycaemic control was
linked to a higher abundance of Staphylococci and
Streptococci [11].
Optimal treatment of infection relies on accurate diag-
nosis of the microbes present and delivery of appropriate
antimicrobial treatment. Failure to effectively treat the
infection in diabetic foot ulcers leads to progressive tis-
sue damage, disrupted wound healing, and serious com-
plications such as osteomyelitis [39]. Due to the reliance
on traditional laboratory culture, many clinics underesti-
mate wound flora, as highlighted by our study and
others, who compared laboratory culture with molecular
methods, discovering that in 45 % of cases an
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inappropriate antibiotic was prescribed [33]. Clinical
Practice Guidelines (2012) recommend that only dia-
betic foot ulcers with clinical signs of infection are
treated with antibiotics due to the adverse effects, fi-
nancial costs and increasing risk of antibiotic resistance
[20]. There have been reports that individuals with dia-
betic foot ulcers treated with antibiotics, in the absence
of clinical signs of infection, exhibited significantly im-
proved rates of healing in comparison to those who did
not undergo antibiotic therapy [40]. The clinical guide-
lines do recommend that patients with signs of mild to
moderate infection receive antibiotic therapy targeting
aerobic Gram-positive cocci [20]. In our study, the ma-
jority of bacteria detected in both new and recurring
ulcers were Gram-positive facultative or obligate anaer-
obes, which would require antibiotics with a wider
spectrum of activity to successfully resolve the infec-
tion. Metronidazole is the drug of choice to effectively
treat a range of infections caused by anaerobic bacteria
and it may have an important role to play in the man-
agement of chronic diabetic foot ulcer infection [41],
though the evidence of its effectiveness in these infec-
tions is questionable [42, 43]. The clinical guidelines
also stress that definitive therapy be based on obtaining
appropriate culture results from the clinical laboratory,
however we have shown that the use of clinical culture
alone may severely underestimate the microbial load
within ulcers and cause a delay in appropriate treat-
ment. Culture independent molecular methods, such as
PCR, have revolutionized many areas of clinical micro-
biology [34] and it is crucial that these are applied to
the routine monitoring of infection in diabetic foot ul-
cers to diagnose the pathogens responsible and guide
appropriate treatment, focussing on disruption of the
biofilm.
Conclusions
Due to the minimal differences found in this study be-
tween the bacterial colonisation of new and recurrent,
there is no need to treat with more severe methods for a
secondary ulcer, even though it is associated with a
higher risk of infection [20]. Due to minimal differences
between the bacterial colonisation of new and recurrent
ulcers, there is no need to treat with more severe
methods for a secondary ulcer, even though it is associ-
ated with a higher risk of infection [20].
Our study produced three key findings:
1) The complexity of the bacterial population present
in diabetic foot ulcers is much greater than would
be expected from culture studies alone.
2) There is no significant difference in the bacterial
populations in new and recurrent ulcers, suggesting
that each wound provides a blank canvas for the
development of a unique microbiome within each
diabetic foot ulcer.
3) 16S AS cannot currently identify all organisms
reliably at a species level and this must be taken into
consideration when using this technique to
characterise the microbiome of an infection site.
Greater understanding of the diabetic foot ulcer
microbiome will help guide new strategies to effectively
control the growth of polymicrobial biofilms and im-
prove healing, directly benefiting patients suffering from
these debilitating wounds.
Methods
Subject selection
The protocol for this study was approved by the
National Research Ethics Committee (London, UK) (Study
Reference 13/LO/1509) and the Research and Development
Office (NHS Ayrshire & Arran). Twenty patients with dia-
betes attending the Diabetes/Podiatry clinic at University
Hospital Ayr (NHS Ayrshire & Arran) were selected for this
study and written consent was obtained. Patients were
excluded if they had received antibiotic treatment in
the past 3 months. All study participants were Caucasian,
diagnosed with Type 2 diabetes and the group comprised
of 18 males and 2 females with an age range of 51 to
86 years. Ten subjects were selected with a new ulcer
(within 3 days of ulcer formation) and ten subjects were
selected with a recurring ulcer (any secondary ulcer re-
gardless of location) [44].
Swab sample collection
During a routine visit to the podiatry clinic patients had
their wound dressing changed and ulcer examined. At
this time, standard protocols were followed to sample
the total surface of the foot ulcer with a Regular
FLOQSwab™ (COPAN, Brescia, Italy), which was directly
placed into a tube containing 2 ml of sterile PBS and im-
mediately placed on ice, for DNA isolation. A second
swab (Sterilin, Thermo Scientific, UK) was then used to
sample the same area of the wound and sent to the clin-
ical laboratory at University Hospital, Crosshouse (NHS
Ayrshire & Arran) for standard aerobic and anaerobic
culture. Swab sampling was used as the preferred
method of sampling in this study as it is a less invasive
alternative to ulcer biopsy and limits the risk of introdu-
cing infection in this vulnerable group of patients. Two
control swabs were also was taken of the healthy skin on
the unaffected foot of each patient. Hospital labs gave
results in the form of presence or absence of species or
groups of bacteria. One swab was used for DNA isola-
tion and the other was assessed by aerobic and anaer-
obic culture to discount any bacterial strains, which may
be part of the patient’s normal healthy skin flora.
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Information on current HbA1c levels and the duration
of the diabetes were also taken from the patient. A
Standard PCR was performed to determine the presence
or absence of methicillin-sensitive Staphylococcus aureus
(MSSA) and methicillin-resistant S. aureus (MRSA)
using primers and conditions previously described by
our group [45]. Primer sequences were as follows:
S. aureus: F- ATTTGGTCCCAGTGGTGTGGGTAT,
R-GCTGTGACAATTGCCGTTTGTCGT,
S. aureus mecA primers: F- AACCACCCAATTTGTC
TGCC,
R- TGATGGTATGCAACAAGTCGTAAA.
DNA isolation and purification
The DNA was isolated from bacterial cells carried on
each FLOQSwab™ within 2 h of clinical sample collec-
tion. Bacterial cells were released from FLOQSwabs™
into the 2 ml of PBS by sonicating the samples in a
water bath (Fisherbrand, ThermoFisher Scientific Inc.,
Loughborough, UK) at 35 kHz for 3 × 20s, and vortexing
for 10s. The samples were centrifuged for 5 min at 5223
× g to pellet the cells. DNA was then isolated from each
sample using bead-beating combined with a QIAamp
DNA Mini Kit (Qiagen, UK), according to the manufac-
turer’s instructions. DNA was stored at −20 °C until re-
quired. The concentration and integrity of purified DNA
was measured by NanoDrop analysis (Thermo Scientific,
UK). It was our initial intention in this study to analyse
the microbiome of the healthy control skin of each indi-
vidual to compare with the microbiome of each ulcer.
However, the concentration of DNA isolated from con-
trol samples was extremely low (in the range 0.5-
1.27 ng/μl) and was much lower than the concentration
required for sequencing (20 ng/μL), therefore these sam-
ples were removed from the study and control samples
were analysed by traditional laboratory culture only.
16S amplicon sequencing (16S AS) and sequence analysis
16S AS was performed by GATC Biotech AG (Konstanz,
Germany). DNA samples (total volume 30 μl [20 ng/μL])
were submitted for initial PCR amplification using
primers for the V4 region of the 16S rDNA gene
(515 F- AGAGTTTGATCCTGGCTCAG and 806R
ATTACCGCGGCTGCTGG), producing a 253 bp
product for sequencing. The Illumina HiSeq 2500 plat-
form (Illumina Inc., San Diego, USA) was used to pro-
duce paired-end sequence reads using cyclic reversible
chain termination chemistry. The base call of each se-
quence read was inspected and filtered for quality. Se-
quences below the quality threshold or less than 137 bp
in length were removed. Sequence read pairs were
merged using FLASh [46] and compressed based on
99 % similarity, using the clustering program CD-HIT-
hit [47]. Chimeric clusters were removed using
UCHIME [48], and unique clusters were subjected to
BLASTn [49] analysis. Good quality and unique 16S
rDNA sequences were used as a reference database to
assign operational taxonomic unit (OTU) status to the
clusters. Classification of OTU clusters and the number
of reads within were consolidated to compute the rela-
tive abundance of each species within each sample.
Statistical analyses
Spearman’s rank correlation was used to assess correl-
ation between culture and PCR results using GraphPad
Prism software version 6.
OTU datasets were reduced by log2 transformation so
as to carry out principal component analysis (PCA) and
diversity statistics (Shannon diversity index and Domin-
ance index); the analysis was carried out using PAST
software [50].
An unpaired t-test was applied to compare diversity
statistics and ulcer bacterial characteristics (oxygen tol-
erance, bacterial morphology, and number of OTU)
using GraphPad Prism® software version 6. PCA was
used to reduce the dimensionality of the OTU dataset. A
scree plot was used to determine how many components
emerged. No distinct clusters appeared between the two
groups. Sample 13 was distant from the other samples
and may have been skewing the data. Therefore analysis
was repeated without Sample 13. To determine if dis-
tinct clusters formed for each group on the PCA plots,
new variables were created for each principle component
by using the factor loadings as regression coefficients,
producing a score for each sample. These scores were
then used as outcome variables to compare between
groups.
The contribution of each bacterial class and genera
that represented over 1 % of the group was calculated in
terms of proportion to the overall sample, percentages
were log transformed and an unpaired t-test was used to
compare new and recurrent groups.
Characteristics of the ulcers (bacterial morphology,
Gram type, oxygen tolerance, diversity levels, and com-
mon genera) were correlated to clinical aspects of the
patient (HbA1c levels and duration of diabetes) using
two-tailed Spearman’s correlation in GraphPad Prism.
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